Xarelto Lawsuit Filings Continue To Rising In Federal Court, Wright & Schulte LLC Comments


Xarelto Lawsuit Filings In Federal And State Courts Contend That There Is No Reversal Agent For The Bleeding Side-Effects That Allegedly Occur Due To Taking The Blood Thinner.

xarelto-bleeding-lawsuits-Wright-and-Schulte-LLCXarelto Lawsuit filings continue to mount in the federal multidistrict litigation against Bayer Healthcare and Janssen Pharmaceuticals Inc. alleging Xarelto bleeding side-effects. the the U.S. District Court, Eastern District of Louisiana, Wright & Schulte LLC notes. The updated docket released by the U.S. Judicial Panel on Multidistrict Litigation (JPML) shows that filings of Xarelto lawsuits rose from 220 in February to 311 as of March 17. In December, the JPML consolidated Xarelto bleeding side-effects lawsuits for pretrial proceedings in the Louisiana federal court. The Xarelto lawsuits are filed on behalf of men and women (or their survivors) who experienced serous bleeding, and in some cases, died allegedly as a result of using the blood thinner medication. The Xarelto claims also contend that Bayer Healthcare and Janssen Pharmaceuticals Inc., the maker and marketer of Xarelto, failed to warn physicians and their patients that the blood thinner does not have an antidote to reverse the anticoagulant’s effects. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

“The increase of Xarelto lawsuit filings shows how Xarelto users are continuing to experience significant bleeding events that threaten the life of patients,” comments Wright & Schulte LLC, a nationwide law firm that represents people who have been injured by harmful drug side-effects. “Plaintiffs say in their complaints that they would not have taken Xarelto had they been told about the drug’s side-effects.” Wright & Schulte LLC continues to investigate Xarelto bleeding side-effects claims and offers free legal consultations to patients who believe they have experienced uncontrollable bleeding, hemorrhaging and other side effects due to taking Xarelto and other similar prescription blood thinners. If you would like to speak with the firm’s experienced Xarelto attorneys, call 1-800-399-0795 or you can visit yourlegalhelp.com for more information on this and other prescription drug lawsuits.

Court documents indicate that a Xarelto complaint was filed in the U.S. District Court, Eastern District of Louisiana on behalf of a Louisiana woman who was prescribed Xarelto in October 2013 to treat atrial fibrillation and used the blood thinner medication until February 2014. According to the complaint, the woman was hospitalized on February 17, 2014 for severe bleeding, dizziness, and weakness and had several blood transfusions. The Xarelto lawsuit asserts that as a result of using the Xarelto blood thinner, the woman suffered serious and dangerous side-effects, including the severe bleed and anemia, and experienced other personal and permanent injuries. (Case No. 2:2014cv02669, In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

Wright & Schulte LLC states that Xarelto was approved by the U.S. Food and Drug Administration (FDA) to treat deep vein thrombosis, pulmonary embolism and to reduce the risk of stroke in patients with atrial fibrillation. According to court documents, plaintiffs in the Xarelto complaints assert that Xarelto was promoted as an improvement over warfarin (Coumadin, Jantoven) since Xarelto does not need periodic monitoring with blood tests, as does warfarin, and does not limit a patient’s diet. Warfarin is an FDA-approved blood thinner that has been on the market since 1954. While warfarin may be an older blood thinner, the Xarelto lawsuits claim vitamin K is used as an antidote to reverse the coagulation effects of warfarin. The Xarelto complaints allege that Xarelto has no reversal agent should significant bleeding occur and this warning was only mentioned in the overdosage section and not the original U.S. label that was approved when the drug was first marketed in the United States. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

Court records indicate that not only were Xarelto claims consolidated in federal proceedings, but Xarelto lawsuits filed in Pennsylvania were consolidated in a mass tort program established in January in the Philadelphia Court of Common Pleas. Administrative Judge Kevin Dougherty granted a request to centralize all Xarelto complaints filed in Pennsylvania in the court’s Complex Litigation Center, which handles consolidated litigation. Court documents show that at the time Judge Dougherty established the mass tort litigation in January, there were 75 Xarelto lawsuits pending. According to the court’s case list, there are 148 Xarelto lawsuits pending as of March 17. (In Re: Xarelto Litigation, Case Number 150102349)

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto bleeding lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.